Morse Asset Management Inc Has $393,000 Stake in Leidos Holdings, Inc. (NYSE:LDOS)

Morse Asset Management Inc reduced its position in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 2.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,695 shares of the aerospace company’s stock after selling 75 shares during the quarter. Morse Asset Management Inc’s holdings in Leidos were worth $393,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of LDOS. Key Financial Inc increased its holdings in shares of Leidos by 6.5% in the 2nd quarter. Key Financial Inc now owns 1,141 shares of the aerospace company’s stock valued at $166,000 after purchasing an additional 70 shares during the period. Bleakley Financial Group LLC lifted its position in Leidos by 2.9% in the 1st quarter. Bleakley Financial Group LLC now owns 2,671 shares of the aerospace company’s stock worth $350,000 after buying an additional 76 shares in the last quarter. Somerset Trust Co lifted its position in Leidos by 4.7% in the 2nd quarter. Somerset Trust Co now owns 2,346 shares of the aerospace company’s stock worth $342,000 after buying an additional 106 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Leidos by 3.1% during the 2nd quarter. UMB Bank n.a. now owns 3,569 shares of the aerospace company’s stock valued at $521,000 after buying an additional 107 shares during the period. Finally, Czech National Bank grew its holdings in shares of Leidos by 0.5% during the 1st quarter. Czech National Bank now owns 24,194 shares of the aerospace company’s stock valued at $3,172,000 after acquiring an additional 111 shares in the last quarter. Hedge funds and other institutional investors own 76.12% of the company’s stock.

Insider Buying and Selling

In other news, Director Gary Stephen May sold 1,000 shares of the stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $144.02, for a total value of $144,020.00. Following the completion of the transaction, the director now owns 11,264 shares in the company, valued at approximately $1,622,241.28. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, CEO Thomas Arthur Bell acquired 1,712 shares of the firm’s stock in a transaction on Thursday, August 1st. The shares were bought at an average cost of $145.04 per share, with a total value of $248,308.48. Following the completion of the acquisition, the chief executive officer now owns 22,398 shares of the company’s stock, valued at $3,248,605.92. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Gary Stephen May sold 1,000 shares of the stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total value of $144,020.00. Following the completion of the transaction, the director now directly owns 11,264 shares of the company’s stock, valued at $1,622,241.28. The disclosure for this sale can be found here. 0.96% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research firms recently issued reports on LDOS. Truist Financial lifted their price objective on Leidos from $165.00 to $175.00 and gave the company a “buy” rating in a research report on Thursday, September 5th. JPMorgan Chase & Co. lifted their target price on shares of Leidos from $165.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, July 31st. Citigroup increased their price target on shares of Leidos from $165.00 to $169.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Wells Fargo & Company lifted their price objective on shares of Leidos from $168.00 to $172.00 and gave the company an “overweight” rating in a research note on Thursday, August 1st. Finally, Barclays increased their target price on shares of Leidos from $160.00 to $165.00 and gave the stock an “overweight” rating in a research report on Monday, August 5th. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $163.08.

Leidos Price Performance

Shares of NYSE:LDOS opened at $157.06 on Monday. The company has a market cap of $21.24 billion, a price-to-earnings ratio of 67.70, a PEG ratio of 1.38 and a beta of 0.70. The business has a 50 day moving average price of $151.25 and a 200 day moving average price of $143.09. The company has a quick ratio of 1.11, a current ratio of 1.21 and a debt-to-equity ratio of 0.91. Leidos Holdings, Inc. has a twelve month low of $89.22 and a twelve month high of $159.10.

Leidos (NYSE:LDOS) last issued its quarterly earnings results on Tuesday, July 30th. The aerospace company reported $2.63 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.36. Leidos had a net margin of 2.72% and a return on equity of 28.40%. The firm had revenue of $4.13 billion during the quarter, compared to the consensus estimate of $4.06 billion. During the same period in the prior year, the firm earned $1.80 EPS. The business’s revenue was up 7.7% on a year-over-year basis. Research analysts predict that Leidos Holdings, Inc. will post 8.95 earnings per share for the current year.

Leidos Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 27th. Investors of record on Friday, September 13th will be paid a $0.38 dividend. The ex-dividend date of this dividend is Friday, September 13th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 0.97%. Leidos’s payout ratio is 65.52%.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.